Catalytic inhibitors work by binding to the active sites of enzymes, effectively blocking the enzyme's ability to catalyze reactions. This can prevent the replication and survival of cancer cells. For instance, some inhibitors target kinases, enzymes that add phosphate groups to proteins and play a critical role in cell signaling pathways. By inhibiting these kinases, the signaling pathways that promote cancer cell growth can be disrupted.
